Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease
Joseph Therriault, Stijn Servaes, Cécile Tissot, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4967-4977
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 426
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Harald Hampel, Yan Hu, Jeffrey L. Cummings, et al.
Neuron (2023) Vol. 111, Iss. 18, pp. 2781-2799
Open Access | Times Cited: 116
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
Wagner S. Brum, Nicholas Cullen, Shorena Janelidze, et al.
Nature Aging (2023) Vol. 3, Iss. 9, pp. 1079-1090
Open Access | Times Cited: 106
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 51
Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease
Javier Arranz, Nuole Zhu, Sara Rubio‐Guerra, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 31
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort
Augusto J. Mendes, Federica Ribaldi, Aurélien Lathuilière, et al.
Journal of Neurology (2024) Vol. 271, Iss. 4, pp. 2053-2066
Open Access | Times Cited: 28
Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology
Joseph Therriault, Nicholas J. Ashton, Ilaria Pola, et al.
EBioMedicine (2024) Vol. 102, pp. 105046-105046
Open Access | Times Cited: 25
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
Przemysław R. Kac, Fernándo González‐Ortiz, Andreja Emeršič, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology
Suzanne E. Schindler, Kellen K. Petersen, Benjamin Saef, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 11, pp. 8074-8096
Open Access | Times Cited: 19
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
Joseph Therriault, Marcel S. Woo, Gemma Salvadó, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 16
Plasma p‐tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10‐year window
Yara Yakoub, Fernándo González‐Ortiz, Nicholas J. Ashton, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 2
Plasma biomarkers for Alzheimer’s and related dementias: A review and outlook for clinical neuropsychology
Heather E. Dark, Michael R. Duggan, Keenan A. Walker
Archives of Clinical Neuropsychology (2024) Vol. 39, Iss. 3, pp. 313-324
Open Access | Times Cited: 14
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 12
Alzheimer’s disease biomarkers and their current use in clinical research and practice
T. Hunter, Luís E. Santos, Fernanda Tovar‐Moll, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 12
Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease
Michael Schöll, Inge M.W. Verberk, Marta del Campo, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 10, pp. 100630-100630
Open Access | Times Cited: 12
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Joseph Therriault, Shorena Janelidze, Andréa Lessa Benedet, et al.
Nature Aging (2024) Vol. 4, Iss. 11, pp. 1529-1537
Open Access | Times Cited: 9
Choriocapillaris and Retinal Vascular Alterations in Presymptomatic Alzheimer's Disease
Giulia Corradetti, Deniz Oncel, Shin Kadomoto, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 1, pp. 47-47
Open Access | Times Cited: 8
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Heather E. Dark, Yang An, Michael R. Duggan, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use
Michael Schöll, Agathe Vrillon, Takeshi Ikeuchi, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100056-100056
Open Access | Times Cited: 1
Plasma p‐tau217 and p‐tau217/Aβ1‐42 are effective biomarkers for identifying CSF‐ and PET imaging‐diagnosed Alzheimer's disease: Insights for research and clinical practice
Xiaomei Zhong, Qiang Wang, Mingfeng Yang, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 1
Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood
Jianman Wang, Xing Lü, Yao He
Biosensors (2025) Vol. 15, Iss. 2, pp. 85-85
Open Access | Times Cited: 1
Influence of cognitive impairment and race on plasma p‐Tau217 in two diverse cohorts
Ashima Nayyar, Mei‐Ling Li, Victor Sotelo, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1
Decreased water exchange rate across the blood–brain barrier throughout the Alzheimer's disease continuum: Evidence from Chinese data
Guanqun Chen, Hui Li, Xingfeng Shao, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Cut‐points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice
Jemma Hazan, Kathy Liu, Jeremy D. Isaacs, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease
Robert A. Rissman, M C Donohue, Oliver Langford, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top